Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1359 (118th)

Modernizing Opioid Treatment Access Act

referredUnited States· United States Congress· EN

Introduced

3 March 2023

Last action

10 March 2023 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Norcross, Donald [D-NJ-1], Rep. Bacon, Don [R-NE-2], Rep. Kuster, Ann M. [D-NH-2], Rep. Trone, David J. [D-MD-6], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Tonko, Paul [D-NY-20], Rep. Pettersen, Brittany [D-CO-7], Sen. Kim, Andy [D-NJ], Rep. Higgins, Brian [D-NY-26], Rep. Perez, Marie Gluesenkamp [D-WA-3], Rep. Houlahan, Chrissy [D-PA-6], Rep. Huffman, Jared [D-CA-2], Rep. Vargas, Juan [D-CA-52], Rep. Kildee, Daniel T. [D-MI-5], Rep. Craig, Angie [D-MN-2], Rep. Crockett, Jasmine [D-TX-30], Rep. Budzinski, Nikki [D-IL-13], Colin Allred, Rep. Trahan, Lori [D-MA-3], Rep. Harder, Josh [D-CA-9], Rep. Davis, Donald G. [D-NC-1], Rep. Auchincloss, Jake [D-MA-4], Rep. Boyle, Brendan F. [D-PA-2], Rep. Correa, J. Luis [D-CA-46], Rep. Underwood, Lauren [D-IL-14], Rep. Balint, Becca [D-VT-At Large], Rep. DeSaulnier, Mark [D-CA-10], Rep. Cherfilus-McCormick, Sheila [D-FL-20], Rep. Wild, Susan [D-PA-7], Rep. Lofgren, Zoe [D-CA-18], Rep. Watson Coleman, Bonnie [D-NJ-12], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Quigley, Mike [D-IL-5], Rep. Levin, Mike [D-CA-49], Rep. Gottheimer, Josh [D-NJ-5], Rep. DelBene, Suzan K. [D-WA-1], Rep. Mullin, Kevin [D-CA-15], Rep. Mrvan, Frank J. [D-IN-1], Rep. Phillips, Dean [D-MN-3], Rep. Panetta, Jimmy [D-CA-19], Rep. Larsen, Rick [D-WA-2], Rep. Bonamici, Suzanne [D-OR-1], Rep. Deluzio, Christopher R. [D-PA-17], Rep. Espaillat, Adriano [D-NY-13], Rep. Kilmer, Derek [D-WA-6], Rep. Clarke, Yvette D. [D-NY-9], Rep. McGovern, James P. [D-MA-2], Rep. Wasserman Schultz, Debbie [D-FL-25]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Modernizing Opioid Treatment Access Act This bill expands access to methadone for an individual's unsupervised use to treat opioid use disorder (OUD). (Typically, methadone must be dispensed to individuals in person through opioid treatment programs.) The bill (1) waives provisions of the Controlled Substances Act that require qualified practitioners to obtain a separate registration from the Drug Enforcement Administration (DEA) to prescribe and dispense methadone to treat OUD, and (2) requires the Substance Abuse and Mental Health Services Administration and the DEA to jointly report on the waiver. Additionally, the bill directs the DEA to register certain practitioners to prescribe methadone that is dispensed through a pharmacy for an individual's unsupervised use. Qualified practitioners must be licensed or authorized to prescribe controlled substances, and they must either work for an opioid treatment program or be a physician or psychiatrist with a specialty certification in addiction medicine. A state may request that the DEA stop registering such practitioners in its jurisdiction. Individuals who receive methadone for unsupervised use must continue to have access to other care through an opioid treatment program. For purposes of the waiver, the bill also requires the exclusive use of electronic prescribing, establishes prescription limits, and sets out requirements for informed consent. Further, the bill permits the use of telehealth to provide methadone treatment and related services if the state and the Department of Health and Human Services jointly determine the use is feasible and appropriate.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 3 March 2023

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 3 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 3 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 10 March 2023

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 3 March 2023

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 3 March 2023

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 3 March 2023

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 73 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.